Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 33.88
(-1.83%)
AUD 33.88
(-1.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.74 Billion | 1.48 Billion | 1.52 Billion | 1.79 Billion | 1.23 Billion | 1.02 Billion |
| Cost of Revenue | 698.4 Million | 601.55 Million | 582.62 Million | 667.2 Million | 414.47 Million | 340.44 Million |
| Gross Profit | 1.04 Billion | 885.33 Million | 938.67 Million | 1.12 Billion | 818.97 Million | 688.86 Million |
| Operating Expenses | 691 Million | 567.38 Million | 506.76 Million | 490.37 Million | 442.17 Million | 388.64 Million |
| Selling, General and Administrative Expenses | 492.8 Million | 404.24 Million | 364.11 Million | 364.68 Million | 327.39 Million | 292.25 Million |
| Research and Development Expenses | 198.2 Million | 163.14 Million | 142.64 Million | 125.69 Million | 114.78 Million | 96.39 Million |
| Other Expenses | - | -7.6 Million | 40.2 Million | 32.4 Million | -16.8 Million | 3.3 Million |
| Cost and Expenses | 1.38 Billion | 1.16 Billion | 1.08 Billion | 1.15 Billion | 856.65 Million | 729.09 Million |
| Operating Income | 353.4 Million | 317.95 Million | 431.91 Million | 633.82 Million | 376.79 Million | 300.21 Million |
| Interest Expense | 18.2 Million | 6.27 Million | 4.53 Million | 4.59 Million | 3.77 Million | 2.4 Million |
| Income Tax Expense | 103.1 Million | 72.72 Million | 117.91 Million | 178.38 Million | 80.58 Million | 73.92 Million |
| Earnings before Tax | 235.7 Million | 307 Million | 467.02 Million | 660.39 Million | 358.87 Million | 274.77 Million |
| Net Income | 132.6 Million | 250.3 Million | 376.9 Million | 524.2 Million | 287.3 Million | 209.2 Million |
| Earnings Per Share Basic | 0.23 | 0.41 | 0.61 | 0.84 | 0.48 | 0.37 |
| Earnings Per Share Diluted | 0.23 | 0.40 | 0.60 | 0.83 | 0.48 | 0.36 |
| Weighted Average Shares Outstanding | 586.72 Million | 578.14 Million | 576.94 Million | 575.65 Million | 574.19 Million | 572.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 586.17 Million | 581.63 Million | 579.99 Million | 579.04 Million | 579.04 Million | 578.05 Million |
| Gross Margin | 0.60 | 0.60 | 0.62 | 0.63 | 0.66 | 0.67 |
| EBIT Margin | 0.26 | 0.28 | 0.34 | 0.40 | 0.35 | 0.33 |
| Profit Margin | 0.08 | 0.17 | 0.25 | 0.29 | 0.23 | 0.20 |
| EBITDA | 444.8 Million | 433.7 Million | 605.1 Million | 808.2 Million | 435.4 Million | 337.6 Million |
| Earnings Before Tax Margin | 0.20 | 0.21 | 0.28 | 0.35 | 0.31 | 0.29 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 939.1 Million | 1.75 Billion | 803.7 Million | 890.5 Million | 1.48 Billion | 690.6 Million |
| Cost of Revenue | 380.8 Million | 698.4 Million | 317.6 Million | 365.3 Million | 601.55 Million | 277.4 Million |
| Gross Profit | 558.3 Million | 1.05 Billion | 486.1 Million | 525.2 Million | 885.33 Million | 413.2 Million |
| Operating Expenses | 357.5 Million | 805.3 Million | 338.2 Million | 307.1 Million | 567.38 Million | 299.2 Million |
| Selling, General and Administrative Expenses | 256.2 Million | - | 236.6 Million | 229.6 Million | - | 202.3 Million |
| Research and Development Expenses | 101.3 Million | - | 96.9 Million | 90.1 Million | - | 84.2 Million |
| Other Expenses | - | -118.1 Million | - | - | -7.6 Million | - |
| Cost and Expenses | 738.3 Million | 1.5 Billion | 655.8 Million | 672.4 Million | 1.16 Billion | 576.6 Million |
| Operating Income | 200.8 Million | 253.9 Million | 152.6 Million | 205.5 Million | 317.95 Million | 126.7 Million |
| Interest Expense | - | 18.2 Million | 8.1 Million | 5.14 Million | 6.27 Million | 1.04 Million |
| Income Tax Expense | 69.8 Million | 103.1 Million | 33.29 Million | 59.3 Million | 72.72 Million | 18.4 Million |
| Earnings before Tax | 95.1 Million | 235.7 Million | 140.6 Million | 213.7 Million | 307 Million | 114.3 Million |
| Net Income | 25.3 Million | 132.6 Million | 107.3 Million | 154.4 Million | 250.3 Million | 95.9 Million |
| Earnings Per Share Basic | 0.04 | - | 0.18 | 0.26 | - | 0.16 |
| Earnings Per Share Diluted | 0.04 | - | 0.18 | 0.26 | - | 0.17 |
| Weighted Average Shares Outstanding | 596.76 Million | 581.97 Million | 583.15 Million | 583.06 Million | 578.14 Million | 581.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 587.81 Million | 586.17 Million | 584.54 Million | 582.75 Million | 581.63 Million | 580.5 Million |
| Gross Margin | 0.59 | 0.60 | 0.60 | 0.59 | 0.60 | 0.60 |
| EBIT Margin | 0.26 | - | 0.25 | 0.27 | - | 0.25 |
| Profit Margin | 0.03 | 0.08 | 0.13 | 0.17 | 0.17 | 0.14 |
| EBITDA | 246.4 Million | - | 198.4 Million | 240 Million | - | 169.5 Million |
| Earnings Before Tax Margin | 0.21 | 0.14 | 0.19 | 0.23 | 0.21 | 0.18 |
9034
NOX
3002
MPP
3624
MEDICO